Activation of nuclear factor-κB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E

Biochemical Pharmacology

Volumn 59, Issue 4, 2000, Pages 427-434

  Li, Yixin ^a   Glauert, Howard P ^a   Spear, Brett T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Hepatocarcinogenesis; Hepatoma cells; Liver; NF B; Peroxisome proliferators; Transcription

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; CIPROFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOCHEMISTRY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TUMOR CELL LINE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CLOFIBRIC ACID; DRUG INTERACTIONS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; PEROXISOME PROLIFERATORS; RATS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0033976075     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00339-1     Document Type: Article

References (43)

1. Miyamoto S., Verma I.M. REL/NF-κB/IκB story. Adv Cancer Res. 66:1995;255-292.
2. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 10:1994;405-455.
3. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family Intimate tales of association and dissociation . Genes Dev. 9:1995;2723-2735.
4. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
5. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB, An oxidative stress-response transcription factor of eukaryotic cells. Free Radic Res Commun. 17:1992;221-237.
6. Tewari M., Dobrzanski P., Mohn K.L., Cressman D.E., Hsu J.-C., Bravo R., Taub R. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κb site-binding complex. Mol Cell Biol. 12:1992;2898-2908.
7. Cressman D.E., Greenbaum L.E., Haber B.A., Taub R. Rapid activation of post-hepatectomy factor/nuclear factor κB in hepatocytes, a primary response in the regenerating liver. J Biol Chem. 269:1994;30429-30453.
8. FitzGerald M.J., Webber E.M., Donovan J.R., Fausto N. Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration. Cell Growth Differ. 6:1995;417-427.
9. Menegazzi M., Carcereri-DePrati A., Suzuki H., Shinozuka H., Pibiri M., Piga R., Columbano A., Ledda-Columbano G.M. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-κB and AP-1 or with expression of tumor necrosis factor α Hepatology. 25:1997;585-592.
10. Betts J.C., Cheshire J.K., Akira S., Kishimoto T., Woo P. The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem. 268:1993;25624-25631.
11. Ron D., Hebener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:1992;439-453.
12. Li Y., Leung L.K., Spear B.T., Glauert H.P. Activation of hepatic NF-κB by phenobarbital in rats. Biochem Biophys Res Commun. 229:1996;982-989.
13. Li Y., Leung L.K., Glauert H.P., Spear B.T. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-κB activity. Carcinogenesis. 17:1996;2305-2309.
14. Nilakantan V., Spear B.T., Glauert H.P. Liver-specific catalase expression in transgenic mice inhibits NF-κBB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis. 19:1998;631-637.
15. Reddy J.K., Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans . CRC Crit Rev Toxicol. 12:1983;1-58.
16. Rao M.S., Reddy J.K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. 8:1987;631-636.
17. Green S. Receptor-mediated mechanisms of peroxisome proliferators. Biochem Pharmacol. 43:1992;393-401.
18. Osumi T., Wen J.-K., Hashimoto T. Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene. Biochem Biophys Res Commun. 175:1991;866-871.
19. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
20. Zhang B., Marcus S.L., Sajjadi F.G., Alvares K., Reddy J.K., Subramani S., Rachubinski R.A., Capone J.P. Identification of a peroxisome proliferator-response element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA. 89:1992;7541-7545.
21. Freedman A.R., Sharma R.J., Nabel G.J., Emerson S.G., Griffin G.E. Cellular distribution of nuclear factor κB binding activity in rat liver. Biochem J. 287:1992;645-649.
22. Spear B.T., Longley T., Moulder S., Wang S.L., Peterson M.L. A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. DNA Cell Biol. 14:1995;635-642.
23. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
24. Spear B.T., Tilghman S.M. Role of α-fetoprotein regulatory elements in transcriptional activation in transient heterokaryons. Mol Cell Biol. 10:1990;5047-5054.
25. Poosch M.S., Yamazaki R.K. Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim Biophys Acta. 884:1986;585-593.
26. Henry K., O'Brien M.L., Clevenger W., Jow L., Noonan D.J. Peroxisome proliferator-activated receptor response specificities as defined in yeast and mammalian cell transcription assays. Toxicol Appl Pharmacol. 132:1995;317-324.
27. Garner M., Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions Application to components of the Escherichia coli lactose operon regulatory system . Nucleic Acids Res. 9:1981;3047-3057.
28. Costa R.H., Grayson D.R., Darnell J.E. Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes. Mol Cell Biol. 9:1989;1415-1425.
29. Gill JL, Design and Analysis of Experiments in the Animal and Medical Sciences. Iowa State University Press, Ames, IA, 1978.
30. Marcus S.L., Miyata K.S., Zhang B., Subramini S., Rachubinski R.A., Capone J.P. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci USA. 90:1993;5723-5727.
31. Zhang B., Marcus S.L., Miyata K.S., Subramani S., Capone J.P., Rachubinski R.A. Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J Biol Chem. 268:1993;12939-12945.
32. Osumi T., Yokota S., Hashimoto T. Proliferation of peroxisomes and induction of peroxisomal β-oxidation enzymes in rat hepatoma H4IIEC3 by ciprofibrate. J Biochem (Tokyo). 108:1990;614-621.
33. Brocard C., Es-Souni M., Ramirez L.C., Latruffe N., Bournot P. Stimulation of peroxisomal palmitoyl-CoA oxidase activity by ciprofibrate in hepatic cell lines Comparative studies in FAO, MH1C1 and HepG2 cells . Biol Cell. 77:1993;37-41.
34. Daffada A.A.I., Murray E.J., Young S.P. Control of activator protein-1 and nuclear factor kappa B activity by interleukin-1, interleukin-6 and metals in HEPG2 cells. Biochim Biophys Acta. 1222:1994;234-240.
35. Costa R.H. Hepatocyte nuclear factor 3/forkhead protein family Mammalian transcription factors that possess divergent cellular expression patterns and binding specificities . Tronche R., Yaniv M. Liver Gene Expression. 1994;183-205 R.G. Landes Co, New York.
36. Devalaraja R.M., Barve S.J., Barve S., McClain C.J. Anti-TNF antibody protection in vivo against acetaminophen induced liver injury. FASEB J. 10:1996;A167.
37. van Zandwijk N. N-Acetylcysteine (NAC) and glutathione (GSH) Antioxidant and chemopreventative properties, with special reference to lung cancer . J Cell Biochem Suppl. 22:1995;24-32.
38. Pahl H.L., Baeuerle P.A. Oxygen and the control of gene expression. Bioessays. 16:1994;497-502.
39. Li Y, Tharappel JC, Cooper S, Glenn M, Glauert HP and Spear BT, Expression of the hydrogen peroxide generating enzyme fatty acyl CoA oxidase activates NFκB. DNA Cell Biol, in press.
40. Goeptar A.R., Scheerens H., Vermeulen N.P.E. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol. 25:1995;25-65.
41. Sha W.C., Liou H.-C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
42. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc Natl Acad Sci USA. 92:1995;7080-7084.
43. 2-generating peroxisomal urate oxidase. Cancer Res. 56:1996;4846-4852.